Massive plus for sure. Even better than cutting a decade of research to less than a year for SARS-CoV-2 because most of the lessons learned from SARS-CoV turned

Massive plus for sure. Even better than cutting a decade of research to less than a year for SARS-CoV-2 because most of the lessons learned from SARS-CoV turned out to apply, because in this case the existing vaccines are already tried and effective (and presumably the new clade is not different enough to change that in any significant way).